Alpelisib Not Yet Recruiting Phase 1 Trials for Meningiomas Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03631953Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas